Literature DB >> 21908619

Molecular identification of β-citrylglutamate hydrolase as glutamate carboxypeptidase 3.

François Collard1, Didier Vertommen, Stefan Constantinescu, Lieven Buts, Emile Van Schaftingen.   

Abstract

β-Citrylglutamate (BCG), a compound present in adult testis and in the CNS during the pre- and perinatal periods is synthesized by an intracellular enzyme encoded by the RIMKLB gene and hydrolyzed by an as yet unidentified ectoenzyme. To identify β-citrylglutamate hydrolase, this enzyme was partially purified from mouse testis and characterized. Interestingly, in the presence of Ca(2+), the purified enzyme specifically hydrolyzed β-citrylglutamate and did not act on N-acetyl-aspartylglutamate (NAAG). However, both compounds were hydrolyzed in the presence of Mn(2+). This behavior and the fact that the enzyme was glycosylated and membrane-bound suggested that β-citrylglutamate hydrolase belonged to the same family of protein as glutamate carboxypeptidase 2 (GCP2), the enzyme that catalyzes the hydrolysis of N-acetyl-aspartylglutamate. The mouse tissue distribution of β-citrylglutamate hydrolase was strikingly similar to that of the glutamate carboxypeptidase 3 (GCP3) mRNA, but not that of the GCP2 mRNA. Furthermore, similarly to β-citrylglutamate hydrolase purified from testis, recombinant GCP3 specifically hydrolyzed β-citrylglutamate in the presence of Ca(2+), and acted on both N-acetyl-aspartylglutamate and β-citrylglutamate in the presence of Mn(2+), whereas recombinant GCP2 only hydrolyzed N-acetyl-aspartylglutamate and this, in a metal-independent manner. A comparison of the structures of the catalytic sites of GCP2 and GCP3, as well as mutagenesis experiments revealed that a single amino acid substitution (Asn-519 in GCP2, Ser-509 in GCP3) is largely responsible for GCP3 being able to hydrolyze β-citrylglutamate. Based on the crystal structure of GCP3 and kinetic analysis, we propose that GCP3 forms a labile catalytic Zn-Ca cluster that is critical for its β-citrylglutamate hydrolase activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21908619      PMCID: PMC3207455          DOI: 10.1074/jbc.M111.287318

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

2.  Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity.

Authors:  M N Pangalos; J M Neefs; M Somers; P Verhasselt; M Bekkers; L van der Helm; E Fraiponts; D Ashton; R D Gordon
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

3.  Immunocytochemical localization of beta-citryl-L-glutamate in primary neuronal cells and in the differentiation of P19 mouse embryonal carcinoma cells into neuronal cells.

Authors:  M Narahara; K Tachibana; S Adachi; A Iwasa; A Yukii; M Hamada-Kanazawa; Y Kawai; M Miyake
Journal:  Biol Pharm Bull       Date:  2000-11       Impact factor: 2.233

4.  A beta-citryl-L-glutamate-hydrolysing enzyme in rat testes.

Authors:  M Miyake; T Innami; Y Kakimoto
Journal:  Biochim Biophys Acta       Date:  1983-10-18

5.  Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II.

Authors:  C H Halsted; E H Ling; R Luthi-Carter; J A Villanueva; J M Gardner; J T Coyle
Journal:  J Biol Chem       Date:  1998-08-07       Impact factor: 5.157

6.  Molecular identification of mammalian phosphopentomutase and glucose-1,6-bisphosphate synthase, two members of the alpha-D-phosphohexomutase family.

Authors:  Pushpa Maliekal; Tatiana Sokolova; Didier Vertommen; Maria Veiga-da-Cunha; Emile Van Schaftingen
Journal:  J Biol Chem       Date:  2007-09-05       Impact factor: 5.157

7.  Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III.

Authors:  Klara Hlouchova; Cyril Barinka; Jan Konvalinka; Jacek Lubkowski
Journal:  FEBS J       Date:  2009-08       Impact factor: 5.542

8.  Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.

Authors:  Jeroen R Mesters; Cyril Barinka; Weixing Li; Takashi Tsukamoto; Pavel Majer; Barbara S Slusher; Jan Konvalinka; Rolf Hilgenfeld
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

9.  Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.

Authors:  Cyril Barinka; Pavel Sácha; Jan Sklenár; Petr Man; Karel Bezouska; Barbara S Slusher; Jan Konvalinka
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

10.  Ovulation-selective genes: the generation and characterization of an ovulatory-selective cDNA library.

Authors:  A Hourvitz; E Gershon; J D Hennebold; S Elizur; E Maman; C Brendle; E Y Adashi; N Dekel
Journal:  J Endocrinol       Date:  2006-03       Impact factor: 4.286

View more
  10 in total

1.  CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation.

Authors:  Thomas W Miller; David R Soto-Pantoja; Anthony L Schwartz; John M Sipes; William G DeGraff; Lisa A Ridnour; David A Wink; David D Roberts
Journal:  J Biol Chem       Date:  2015-08-26       Impact factor: 5.157

2.  ATP-binding Cassette Subfamily C Member 5 (ABCC5) Functions as an Efflux Transporter of Glutamate Conjugates and Analogs.

Authors:  Robert S Jansen; Sunny Mahakena; Marcel de Haas; Piet Borst; Koen van de Wetering
Journal:  J Biol Chem       Date:  2015-10-29       Impact factor: 5.157

3.  Structural and biochemical characterization of the folyl-poly-γ-l-glutamate hydrolyzing activity of human glutamate carboxypeptidase II.

Authors:  Michal Navrátil; Jakub Ptáček; Pavel Šácha; Jana Starková; Jacek Lubkowski; Cyril Bařinka; Jan Konvalinka
Journal:  FEBS J       Date:  2014-06-17       Impact factor: 5.542

4.  Modulation of plasma and urine metabolome in colorectal cancer survivors consuming rice bran.

Authors:  Iman Zarei; Renee C Oppel; Erica C Borresen; Regina J Brown; Elizabeth P Ryan
Journal:  Integr Food Nutr Metab       Date:  2019-04-05

5.  Effects of Acute and Chronic Resistance Exercise on the Skeletal Muscle Metabolome.

Authors:  Sebastian Gehlert; Patrick Weinisch; Werner Römisch-Margl; Richard T Jaspers; Anna Artati; Jerzy Adamski; Kenneth A Dyar; Thorben Aussieker; Daniel Jacko; Wilhelm Bloch; Henning Wackerhage; Gabi Kastenmüller
Journal:  Metabolites       Date:  2022-05-16

6.  1H NMR Metabolic Profiling of Earthworm (Eisenia fetida) Coelomic Fluid, Coelomocytes, and Tissue: Identification of a New Metabolite-Malylglutamate.

Authors:  Corey M Griffith; Preston B Williams; Luzineide W Tinoco; Meredith M Dinges; Yinsheng Wang; Cynthia K Larive
Journal:  J Proteome Res       Date:  2017-08-16       Impact factor: 4.466

7.  Rimklb mutation causes male infertility in mice.

Authors:  Koji Maekura; Satoshi Tsukamoto; Michiko Hamada-Kanazawa; Masaoki Takano
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

8.  N-acetylaspartate (NAA) induces neuronal differentiation of SH-SY5Y neuroblastoma cell line and sensitizes it to chemotherapeutic agents.

Authors:  Carmela Mazzoccoli; Vitalba Ruggieri; Tiziana Tataranni; Francesca Agriesti; Ilaria Laurenzana; Angelo Fratello; Nazzareno Capitanio; Claudia Piccoli
Journal:  Oncotarget       Date:  2016-05-03

9.  Confronting the catalytic dark matter encoded by sequenced genomes.

Authors:  Kenneth W Ellens; Nils Christian; Charandeep Singh; Venkata P Satagopam; Patrick May; Carole L Linster
Journal:  Nucleic Acids Res       Date:  2017-11-16       Impact factor: 16.971

10.  Mouse glutamate carboxypeptidase II (GCPII) has a similar enzyme activity and inhibition profile but a different tissue distribution to human GCPII.

Authors:  Tomáš Knedlík; Barbora Vorlová; Václav Navrátil; Jan Tykvart; František Sedlák; Šimon Vaculín; Miloslav Franěk; Pavel Šácha; Jan Konvalinka
Journal:  FEBS Open Bio       Date:  2017-08-29       Impact factor: 2.693

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.